$178.39
+0.00 (+0.00%)
Last updated: Apr 16, 2026 00:30
Fundamentals Overview
Masimo Corporation is near the high of its 52-week range with moderate valuation, trading relatively flat today.
Valuation moderate
Intrinsic value (DCF)
-82.7% downside vs price
Risk (Beta)
1.2 — in line vol
BullzEye Analysis
Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.
Composite Signal
Supporting (Buy):
3M vs S&P 500: +34.2% · 3M vs Healthcare sector: +41%
Pressures (Sell):
DCF 82.7% downside vs price
Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.
Key Stats
About
Ratings & Grades at a Glance
Overall rating: C-. Recent institutional grades: mixed. Current institutional positions: Buy: 7, Equal Weight: 1, Hold: 4, Market Perform: 1, Neutral: 2, Outperform: 3, Overweight: 12.
Valuation & Ratios
Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.
DCF vs price: DCF estimate is $30.81; current price is $178.39. That’s a -82.7% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.
| Metric | Value |
|---|---|
| Valuation | |
| P/E (TTM) | N/A |
| DCF value (model) | $30.81 (-82.7% vs price) |
| PEG (TTM) | N/A |
| P/B (TTM) | 13.26 |
| P/S (TTM) | 6.12 |
| P/FCF (TTM) | 47.71 |
| Liquidity & enterprise | |
| Current Ratio (TTM) | 2.49 |
| Quick Ratio (TTM) | 1.47 |
| Cash Ratio (TTM) | 0.41 |
| Profitability | |
| ROE (TTM) | N/A |
| ROA (TTM) | N/A |
| Revenue growth (YoY) | N/A |
| Net margin (TTM) | -9.92% |
| Gross margin (TTM) | 61.9% |
| Operating margin (TTM) | 20.3% |
| Debt to equity (TTM) | N/A |
Latest News
News loads when you open this tab.
Price Target, Ratings & Grades
Analyst price targets, consensus, rating snapshot, and institutional grades for MASI.
Analyst Sentiment at a Glance
Stock Grades (Institutions)
| Institution | Action | Previous Grade | New Grade | Date |
|---|---|---|---|---|
| Raymond James | downgrade | Outperform | Market Perform | 2026-03-27 |
| Wells Fargo | downgrade | Overweight | Equal Weight | 2026-02-18 |
| BTIG | downgrade | Buy | Neutral | 2026-02-18 |
| BTIG | maintain | Buy | Buy | 2025-12-04 |
| BTIG | maintain | Buy | Buy | 2025-11-24 |
| BTIG | maintain | Buy | Buy | 2025-11-05 |
| Wells Fargo | maintain | Overweight | Overweight | 2025-11-05 |
| BTIG | maintain | Buy | Buy | 2025-09-11 |
| Piper Sandler | maintain | Overweight | Overweight | 2025-08-06 |
| Wells Fargo | maintain | Overweight | Overweight | 2025-05-07 |
| Raymond James | maintain | Outperform | Outperform | 2025-05-07 |
| Piper Sandler | maintain | Overweight | Overweight | 2025-05-07 |
| Needham | maintain | Hold | Hold | 2025-04-10 |
| Piper Sandler | maintain | Overweight | Overweight | 2025-02-26 |
| Wells Fargo | maintain | Overweight | Overweight | 2025-02-26 |
| Needham | maintain | Hold | Hold | 2025-02-26 |
| Needham | maintain | Hold | Hold | 2025-01-22 |
| Needham | maintain | Hold | Hold | 2025-01-16 |
| Raymond James | maintain | Outperform | Outperform | 2024-12-27 |
| Piper Sandler | maintain | Overweight | Overweight | 2024-12-18 |
| Wells Fargo | maintain | Overweight | Overweight | 2024-12-11 |
| Stifel | maintain | Buy | Buy | 2024-11-22 |
| Raymond James | upgrade | Market Perform | Outperform | 2024-11-06 |
| Wells Fargo | maintain | Overweight | Overweight | 2024-11-06 |
| Piper Sandler | maintain | Overweight | Overweight | 2024-11-06 |
| BTIG | maintain | Buy | Buy | 2024-10-14 |
| Piper Sandler | maintain | Overweight | Overweight | 2024-08-07 |
| Piper Sandler | upgrade | Neutral | Overweight | 2024-06-03 |
| Piper Sandler | maintain | Neutral | Neutral | 2024-05-08 |
| Stifel | upgrade | Hold | Buy | 2024-04-15 |